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CHO cells express both of the phosphoinositidase C-linked G-proteins G, and G,, G,,a is some 2.5-fold more highly expressed than G,a in 
membranes of these cells. Following transfection and stable expression of CHO cells wtth DNA encoding the human muscarimc Ml acetylcholine 
(HMl) receptor, chronic treatment of the cells with the cholinergic agonist carbachol resulted in down-regulation of membrane levels of both G,a 
and G,I,. Dose-response curves to carbachol produced identical EC,, values for agonist-Induced down-regulation of the two G-proteins and both 
were down-regulated with the same time course. These data indicate that the HMl receptor interacts with and activates both G,a and G,,a 
equivalently and non-selectively in a whole cell system m which the receptor has access to both G-proteins. 
Guanine nucleotide bmdmg protein; Phosphohpase C: Inosttol trisphosphate; Muscarinic acetylcholine receptor 
1. INTRODUCTION 
Agonist regulation of cellular phosphoinositidase C 
activities appear to involve at least two separate mecha- 
nisms [I]. In one situation, the receptor interacts with 
and activates a pertussis toxin-sensitive heterotrimeric 
G-protein and by so doing liberates /Ir complex which 
is then able to activate the enzyme phospholipase Cp2 
and/or phospholipase C/I3 [24]. In the more common 
situation, the receptor activates one or more members 
of the G, family of G-proteins [5]. The GTP-ligated CI 
subunits of at least G,, G,, and G,, are then able to 
interact with and activate phospholipase Cpl [6,7]. 
Because of the very marked sequence similarity of G, 
and G,, [8] it has been difficult to adequately purify 
these two G-proteins away from each other [9,10] and 
thus traditional reconstitution approaches have not 
been able to indicate whether a receptor is able to selec- 
tively interact with one or other of these polypeptides. 
Studies involving transient transfection assays have 
clearly indicated the potential for each of Gqtl and G, 1~ 
to act as activators of inositol phosphate generation 
[6,7] but again have been unable to examine the poten- 
tial selectivity of receptors for each of these G-proteins. 
We have recently noted in a number of systems that 
activation of a G-protein-linked receptor can result in 
down-regulation of membrane levels of the G-protein(s) 
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which is activated by that receptor without equivalent 
effects on other G-proteins [l 11. In CHO cells which 
have been transfected to express the HMl receptor we 
have noted agonist-mediated down-regulation of some 
combination of G, and G,, [12] and demonstrated that 
the mechanism behind this effect is enhanced turnover 
of the G-protein [13]. 
However, previously we have been unable to define 
if this effect involves both G, and G,, and if so whether 
the effect of the receptor on the two G-proteins is equiv- 
alent. In this report we utilize SDS-PAGE systems 
which can resolve these two G-proteins [I 4,151 to exam- 
ine this question. We demonstrate that G, and G,, are 
both down-regulated to a similar extent following car- 
bachol treatment of these cells and that the agonist has 
similar EC,, values for the effects on both G-proteins. 
These data demonstrate that in this in vivo system the 
HMl receptor activates and subsequently down-regu- 
lates both G, and G,l equally and non-selectively. 
2. MATERIALS AND METHODS 
2.1. Cell growth 
HMl expressing CHO cells [16] were grown in tissue culture as 
described previously [12]. In a number of cases the cells were incubated 
in the presence of varying concentrations of the chohnergic agonist 
carbachol prior to cell harvest. Followmg harvest the cells were homo- 
genised with 10 ~01s. of 10 mM Tris-HCI, 0.1 mM EDTA pH 7.5 
(buffer A) and the homogenates centrifuged at 500 x g for 10 min. The 
supernatants from this process were further centrifuged at 48,000 x g 
for 10 min and the pellets from the second centrifugation were washed 
with buffer A and recentrifuged at 48.000 x g for 10 min. Finally the 
pellets were resuspended in buffer A at a protein concentration of 2 
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mg/ml and stored at -80°C. Protein concentration was measured 
accordmg to Lowry et al. [I 71. 
Membranes were resolved by SDS-PAGE m 14 x 16 cm slab gels 
using either the 13% (w/v) acrylamide. 0.25% (w/v) bisacrylamide 
system, as described by Blank et al [14] or m 12 5% (w/v) acrylamide, 
0.0625% bisacrylamide contaimng a lmear (4 8 M) gradient of urea 
[15] to resolve G,z and G,,a. Purified G,/G,, from bovine hver was 
a kmd gift of Dr. J. Exton. Vanderbilt University. TN. USA. Protems 
were transferred to mtrocellulose (Schleicher and Schucll) and blocked 
for 2 h at 37°C with 5% gelatm m phosphate-buffered aahne (PBS) (4 
mM Na,HPO,, 0.27 mM KCI, 0.15 mM KHZPO,, 137 mM NaCI) 
Antiserum CQ3 was generated against a synthetic peptide which rep- 
resents the C-terminal decapeptide which IS common to the a subunits 
of G, and G,, [18]. Antiserum IQB was generated in a similar Pdshion 
against a synthetic peptide corresponding to ammo acids 119-I 34 of 
G,a. This region of the protein differs considerably from the equiva- 
lent region of both G,,a and G,,a. Primary antisera (CQ3. IQB) 
(l:l.OOO dilution) in 1% gelatm-PBS here then added and left over- 
night. The primary antiserum was then removed and the blot was 
washed extensively with distilled water folloued by washes atth PBS 
containing 0.2% (v/v) NP40 and then PBS. Secondary antiserum (don- 
key anti-rabbit IgG coupled to horseradish peroxidase) (Scottish An- 
tibody Production Unit, Carluke, Scotland) m 1% gelatin-PBS has 
added and left for 3 h Removal of the secondary antiserum aas 
followed by the same series of extensive washes of the nitrocellulose 
as detailed following removal of the primary antiserum O-diamsidme 
hydrochloride (Sigma) was employed as the substrate for detection of 
the antibody complex. 
The developed immunoblots were scanned with a Shimadru CS- 
9000 dual wavelength flying-spot laser densitometer on reflectance 
mode at 500 nm. Background was subtracted by scannmg of equiva- 
lent sized areas of nitrocellulose which did not contam immunoreac- 
tive protein The results were analysed on a Shimadzu FDU-3 central 
processing umt enabling quantitation of the immunoblots. 
3. RESULTS 
We have previously demonstrated that sustained car- 
bachol treatment of HM 1 -expressing CHO cells results 
in a reduction in membrane-associated levels of some 
combination of G,a and G, ,a [ 121. These two phospho- 
inositidase C-linked G-proteins comigrate in SDS- 
a 
PAGE (10% (w/v) acrylamide) and as such it has previ- 
ously not been possible to assess directly in a single 
experiment whether both of these G-proteins are regu- 
lated by the receptor. 
HMl expressing CHO cells co-express G,cx and G,,a: 
(Fig. la,b, lanes 1 and 2). Following resolution in the 
13% acrylamide SDS-PAGE system described by Blank 
et al. [14] (Fig. la) immunoblotting with an antiserum 
(CQ3), which was generated against a synthetic peptide 
which is conserved in the primary sequences of these 
two G-proteins, demonstrated separation of a purified 
mixture of these G-proteins (Fig. 1 a, lane 3). HMl- 
expressing CHO cells expressed CQ3 immunoreactive 
polypeptides which comigrated with each of the purified 
proteins from liver. In this system G,a migrates more 
rapidly than G,,a [14]. Resolution of membranes of 
HMl expressing CHO cells in 12.5% acrylamide, 
0.0625% bisacrylamide (w/v) gels which contained a lin- 
ear gradient of 4-8 M urea also resolved two CQ3 reac- 
tive polypeptides (Fig. lb) but in this system G,,a mi- 
grates more rapidly than G,a [ 151. As antiserum CQ3 
interacts equally with these two G-proteins, the higher 
tmmunoreactivity associated with G,,a in both gel sys- 
tems (Fig. la,b) indicates that this polypeptide is more 
highly expressed in CHO cells is than G,a. Analysis of 
a number of immunoblots of membranes of HMl-ex- 
pressing CHO cells following resolution either by the 
method of Blank et al. [14] or in the 12.5% acrylamide. 
0.0625% bisacrylamide (w/v) gels which contained a lin- 
ear gradient of 4--S M urea demonstrated that the rela- 
tive steady-state levels of expression of G,,a:G,a were 
some 2.4: 1 .O. 
Treatment of HMl CHO cells with the cholinergic 
agonist carbachol (lo-’ M. 16 h) reduced membrane- 
associated immunoreactivity corresponding to both 
G, ,a and to G,a (Fig. 1 a,b). Treatment of the cells with 
varying concentrations of carbachol demonstrated that 
half-maximal loss of both G,a and G,,a was achieved 
b 
1 2 3 
1 2 
Fig. 1. HMl expressing CHO cells co-express G,a and G, ,a and both are down-regulated by treatment with carbachol. (a) Membranes (25 pug) 
from HMI expressing CHO cells which were untreated (I). or treated with carbachol (IO-’ M. 16 h) 12). here resolved in the SDS-PAGE system 
of Blank et al. [14] along with 10 ng of a purified mixture of bovine liver G, and G,, [14] containmg approximately equal amounts of these two 
proteins (3). (b) Membranes (25 p(g) from HMI-expressmg CHO cells which were untreated (I). or were treated with carbachol (IO-’ M. 16 h) (2). 
were resolved in the SDS-PAGE system urea gradient gel system described in section 2 In both cases the gels were immunoblotted using antiserum 
CQ3 as primary reagent. 
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Fig. 2. Exposure of HMl expressing CHO cells to varymg concentrations of carbachol results in equtvalent down-regulation of G,,a and G,a. 
HMl expressing CHO cells were treated with varymg concentrattons of carbachol for 16 h. Membranes (25 l(g) prepared from these cells were 
resolved by the urea gradtent system of [15] and tmmunoblotted using antiserum CQ3 as primary reagent. (a) Representattve example of an 
immunoblot from such experiments in whtch the carbachol concentration was varied from 0 (CON) to 10-j M. (b) Composite data of expertments 
derived from cells from individual treatments. Results are displayed as mean + S.E.M. (11 = 4) of the rmmunoreactivity recorded from membranes 
of cells maintained in the absence of carbachol. G,a immunoreacttvtty (open squares), G,,a immunoreactivity (filled diamonds). 
by 16 h treatment with some 10m6 M carbachol (Fig. 2). 
The time-course of down-regulation of Cp and G, ,c1 in 
HMl-expressing CHO cells exposed to carbachol (10m3 
M) was also shown to be equivalent (Fig. 3) with half- 
maximal effects achieved by 4 h. Equivalent data for 
G,a loss, both in terms of time-courses and doseere- 
sponse to carbachol was obtained from experiments in 
which immunoblots were probed with the G,a-specific 
antiserum IQB (data not shown). 
4. DISCUSSION 
Expression of the human muscarinic Ml ace- 
tylcholine receptor in CHO cells has been noted to allow 
cholinergic agonist-dependent down-regulation of the CI 
subunit of a member or members of the G, family of 
G-proteins [12]. This effect is dependent upon the time 
of exposure and the concentration of agonist used [12] 
and mechanistically has been demonstrated to result 
from agonist-enhanced proteolysis of the G-protein(s) 
[13]. It is also specific for G,/G,, as cellular levels of 
other G-proteins are not modified by such treatment 
and is dependent on the receptor as carbachol treatment 
of parental CHO cells does not regulate GJG,, levels 
P21. 
G, and G,, are the best studied and most widely 
expressed of the G-proteins (G,, G,,, G,, and G,6) 
which comprise the G, family of G-proteins [5,8]. A 
series of transfection experiments have shown that the 
c1 subunits of the various members of this family allow 
communication between agonist-occupied receptors 
and, at least, the /I1 isoform of the phospholipase C 
family of effector enzymes [6,7] resulting in the hydrol- 
ysis of phosphatidylinositol-4,5-bisphosphate to gener- 
ate the second messengers inositol-I ,4,5-trisphosphate 
and 1,2-diacylglycerol. 
243 
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Ftg. 3 Exposure of HMl-expressmg CHO cells to carbachol for var- 
ymg ttmes results in equivalent down-regulation of both G,,a and 
G,a. HMI -expressing CHO cells were treated with carbachol (10m3 M) 
for times up to 16 h. Membranes (25pg) prepared from these cells were 
resolved by the urea gradtent system of [15] and immunoblotted using 
antiserum CQ3 as primary reagent. A representative example of an 
immunoblot from such experiments IS dtsplayed. G, ,a immunoreacttv- 
ity (filled diamonds), G,a immunoreactivity (open squares). Seven 
similar experiments were performed on membranes derived from indt- 
vidual treatments of the cells with carbachol. 
To date, it has been impossible to assess how selec- 
tively, if at all, a receptor is able to interact with differ- 
ent members of the G, family when they are expressed 
in the same cell and thus are potentially both available 
to the receptor. Analysis of mRNA by reverse transcrip- 
tase-polymerase chain reaction has shown G,ol and 
G,,a to be co-expressed in these HMI-expressing CHO 
cells [ 131 and that agonist treatment does not alter levels 
of mRNA encoding either of these G-protein CY subunits 
[13]. In a number of systems selective down-regulation 
of the G-proteins which are activated by receptors has 
been observed during chronic exposure on the cells to 
receptor agonists, while cellular levels of other G-pro- 
teins with which the receptor does not interact are un- 
changed [ 111. 
In this study we have used this strategy to examine 
the relative in vivo interactions of the HMl receptor 
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with Gqa and with G,,a. These two G-proteins are some 
90% identical in primary sequence [8] and are of ex- 
tremely similar molecular mass. As such they migrate 
together in many SDS-PAGE systems. We wished to 
use an antiserum which would identify both G-proteins 
equally [18] so that their relative levels in the cell could 
be observed but this required the development of SDS- 
PAGE conditions suitable for resolution of the two pol- 
ypeptides. In this study we have used two such systems. 
In the 13% acrylamide system described by Blank et al. 
[14] G,a migrated more rapidly through the gel than 
G,,a (Fig. la). In contrast, in low bisacrylamide gels 
containing a gradient of urea, the reverse order of mo- 
bility was observed [15]. 
Immunoblotting membranes of HM 1 expressing 
CHO cells with antiserum (CQ3). which was generated 
against a peptide which represents the C-terminal de- 
capeptide which is completely conserved between the a 
subunits of these two G-proteins [18], demonstrated 
that these cells express some 2.5-fold higher steady-state 
levels of G,,a than of G,a. Treatment of the cells with 
carbachol resulted in a down-regulation of both G, and 
G,, without altering levels of any other G-protein (data 
not shown but see [12]). Both varying the concentration 
of carbachol and the time of exposure to the agonist 
resulted in down-regulation of the same proportion of 
each of G, and G,, at each point examined. These re- 
sults clearly indicate that the HMl receptor, at least 
when expressed in CHO cells, does not actively select 
between Gqa and G,,a and interacts with each equally 
based only on their relative cellular levels. G, and G,, 
are widely co-expressed (Milligan, G., Mullaney, I. and 
McCallum, J.F., submitted for publication) and this 
raises obvious questions as to the specific role of each. 
To date the only reported difference between them has 
been in the regulation of TRH receptor function when 
G, or G,, was co-expressed with this receptor in XUZ- 
opus oocytes [19]. Further examination of the individ- 
ual functions of these G-proteins is clearly required. 
Acknouhfgemmts~ These studies were supported by a proJect grant 
from the Wellcome Trust (to G M.). 
REFERENCES 
PI 
121 
[31 
[41 
151 
161 
[71 
PI 
Park, D.. Jhon. D.-Y., Lee, C.-W.. Lee, K-H. and Rhee, S.G. 
(1993) J. Biol. Chem 268, 45734576. 
Camps, M., Carozzi, A., Schnabel. P., Scheer. A., Parker, PJ. 
and Gterschtk, P. (1992) Nature 360. 684686. 
Katz, A., Wu, D. and Simon, M.I. (1992) Nature 360, 686-689. 
Carozzt, A.. Camps, M , Gierschik. P. and Parker, P.J. (1993) 
FEBS Lett. 315, 340-342. 
Sternweis, P.C. and Smrcka. A.V. (1992) Trends Btochem. Sci. 
17, 5022506. 
Wu, D., Katz, A.. Lee, C.-H. and Stmon. M.I. (1992) J. Biol 
Chem. 267, 25798-25802. 
Aragay, A.M., Katz, A. and Stmon, M.I. (1992) J. Biol. Chem 
261. 24983324988. 
Strathmann. M.P and Simon. M.I. (1990) Proc. Natl. Acad. Sci. 
USA 87, 9113-9117. 
Volume 324, number 2 FEBS LETTERS June 1993 
[9] Smrcka, A.V., Helper, J.R., Brown, K.O. and Sternweis, P.C. 
(1991) Science 251. 804-807. 
[lo] Taylor, S.J., Chae, H.Z., Rhee, S.G. and Exton, J.H. (1991) 
Nature 350, 516-518. 
[11] Milligan, G. and Green, A. (1991) Trends Pharmacol. Sci. 12. 
2077209. 
[12] Mullaney. I.. Dodd, M.W., Buckley, N.J. and Milligan, G. (1993) 
Btochem. J. 289. 125-131. 
[15] Milligan, G. (1993) J. Neurochem. (in press). 
[16] Buckley, N.J., Bonner. T.I., Buckley, C.M. and Brann, M.R. 
(1989) Mol. Pharmacol. 35, 4699476. 
[17] Lowry. O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. 
(1951) J. Biol. Chem. 193. 2655275. 
[18] Mitchell. F.M., Mullaney, I.. Godfrey, P.P.. Arkinstall, S.J., 
Wakelam. M.J.O. and Milligan, G. (1991) FEBS Lett. 287, 191- 
194. 
[13] Mitchell, F.M., Buckley, N.J. and Milligan, G. (1993) Biochem. [19] Lipinsky, D., Gershengorn, M.C. and Oron, Y. (1992) FEBS 
J. (in press). Lett. 307, 237-240. 
[14] Blank, J.L., Ross, A.H. and Exton. J.H. (1991) J. Biol. Chem. 
266, 1820618216. 
245 
